HBP Surgery Week 2024

Details

[E-poster - Liver (Liver Disease/Surgery)]

[EP 051] Tumor Thrombectomy Via Surgically Reopened Umbilical Vein As a Palliative Treatment for Patient with Advanced Hepatocellular Carcinoma
TRUONG GIANG NGUYEN 1, MINH TRONG NGUYEN 1, KIEU HUNG NGUYEN 1, NGOC THACH PHAM 1
1 Hepatobiliary - Gastrointestinal Surgery And Oncology, National Hospital of Tropical Diseases, VIETNAM

Background : Portal vein tumor thrombosis is an ominous prognosis factor in patients with HCC. It can cause deadly complications such as liver failure, GI bleeding due to portal hypertension

Methods : We present a case of a patient with huge right liver tumor and multinodular in the left with an extensive portal venous tumor thrombus extending into the main trunk and left portal branch. He had already been resistance to immunotherapy (Atezolizumab plus Bevacizumab) and HAIC. The CT Scanner showed that the tumor thrombosis increased rapidly, to prevent the complications, we performed the surgical tumor thrombectomy using a balloon catheter push to push the thrombus via reopened umbilical vein and ligated the right portal vein

Results : The operated time was 200 minutes with estimated blood loss 550ml. The patient recovered well with no complication. The post-operation CT Scanner show no thrombus in the main portal trunk and the left branch, with the left liver volume increase from 552ml to 705ml after 17 days. He was continued to treat with Levatinib and Radiotherapy. 10 months after the operation, he is treated with HAIC again and his health is stable.

Conclusions : Tumor thrombectomy via the umbilical vein is safe and can be apply as a palliative treatment for patients with advanced HCC.



SESSION
E-poster
E-Session 03/21 ALL DAY